Swalqol in Primary Hyperparathyroidism
The Effect of Parathyroidectomy on Swallowing Related Quality of Life in Primary Hyperparathyroidism
Sponsor: Uşak University
Listed as NCT03968510, this observational or N/A phase trial focuses on Hyperparathyroidism and remains completed. Sponsored by Uşak University, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
-
Jun 2021 — Sep 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
-
Jan 2020 — Jun 2020 [monthly]
Recruiting
-
Jun 2019 — Jan 2020 [monthly]
Recruiting
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Uşak University
For direct contact, visit the study record on ClinicalTrials.gov .